Stay updated on Helix BioPharma Press Releases
Sign up to get notified when there's something new on the Helix BioPharma Press Releases page.

Latest updates to the Helix BioPharma Press Releases page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA new news entry dated 03 Jun 2026 was added announcing the closing of a private placement of convertible debentures. An older post from 09 Sep 2025, the 'Helix BioPharma Announces Presentation at Q3 Investor Summit Virtual on 16 September 2025' post, and the Pipeline navigation item were removed from the News section.SummaryDifference2%

- Check16 days agoChange DetectedA new News item dated 22 May 2026 reports the grant and cancellation of stock options, reflecting ongoing governance and compensation updates. A previous press release dated 05 Sep 2025 about not proceeding with an equity draw-down facility has been removed from the listings, altering the historical financing context on the News page.SummaryDifference2%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedAdds a new news item dated 13 May 2026 announcing strategic board and governance appointments to support financing and Nasdaq uplisting strategy. Removes the August 22, 2025 item regarding the closing of a private placement in preparation for institutional investment and Nasdaq uplisting.SummaryDifference2%

- Check88 days agoChange DetectedAdded a new news item: Helix Biopharma Corp. Announces Financial Results and Filing of Interim Financial Statements as of and for the Three- and Six-Month Periods Ended January 31, 2026. Removed the 2025 Frontiers in Oncology publication on the Effects of L-DOS47 as Monotherapy in NSCLC.SummaryDifference2%

- Check109 days agoChange DetectedAdded 2026 news items, including the World ADC London presentation, LEUMUNA option extension, and AGM voting results. Removed several 2025 items from the News & Media Releases.SummaryDifference6%

- Check181 days agoChange DetectedA new news item titled 'Helix Biopharma Corp. Announces Filing of Interim Financial Statements as of and for the Three-Month Period Ended October 31, 2025' was added to the News page on December 15, 2025. The item 'Helix BioPharma Corp. Signs Capital Raising Agreement with Kerentech Consulting Ltd.' dated May 14, 2025 was removed.SummaryDifference2%

Stay in the know with updates to Helix BioPharma Press Releases
Enter your email address, and we'll notify you when there's something new on the Helix BioPharma Press Releases page.